Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cytori Therapeutics has received a notice of allowance from the US Patent & Trademark Office for a patent application that covers methods of creating a cell-enhanced graft using a closed system to process adipose-derived stem and regenerative cells.
Subscribe to our email newsletter
This patent will specifically protect Cytori’s Celution System-based devices and methods essential in novel cosmetic and reconstructive surgery procedures.
According to Cytori, this is an important development for the company because it creates a stronger barrier-to-entry against potentially competitive methods specifically within the cosmetic and reconstructive surgery market and protects in the US, a product currently on sale in many countries around the world.
The methods and devices covered by this patent may be useful to protect products treating a variety of clinical applications beyond breast reconstruction such as the general repair of soft tissue defects, breast augmentation, facial reconstruction and augmentation, vocal cord repair, soft tissue defects secondary to radiation therapy as well certain urologic and gastrointestinal conditions.